Citation: S. Shiotsuka et S. Isonishi, Differential sensitization by orobol in proliferating and quiescent human ovarian carcinoma cells, INT J ONCOL, 18(2), 2001, pp. 337-342
Authors:
Yamamoto, K
Okamoto, A
Isonishi, S
Ochiai, K
Ohtake, Y
Citation: K. Yamamoto et al., Heat shock protein 27 was up-regulated in cisplatin resistant human ovarian tumor cell line and associated with the cisplatin resistance, CANCER LETT, 168(2), 2001, pp. 173-181
Authors:
Yamamoto, K
Okamoto, A
Isonishi, S
Ochiai, K
Ohtake, Y
Citation: K. Yamamoto et al., A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumorcell line, was associated with apoptosis, BIOC BIOP R, 280(4), 2001, pp. 1148-1154
Authors:
Isonishi, S
Ohkawa, K
Tanaka, T
Howell, SB
Citation: S. Isonishi et al., Depletion of protein kinase C (PKC) by 12-O-tetradecanoylphorbol-13-acetate (TPA) enhances platinum drug sensitivity in human ovarian carcinoma cells, BR J CANC, 82(1), 2000, pp. 34-38
Authors:
Okamoto, A
Woodworth, CD
Yen, K
Chung, J
Isonishi, S
Nikaido, T
Kiyokawa, T
Seo, H
Kitahara, Y
Ochiai, K
Ochiai, K
Tanaka, T
Citation: A. Okamoto et al., Combination therapy with podophyllin and vidarabine for human papillomavirus positive cervical intraepithelial neoplasia, ONCOL REP, 6(2), 1999, pp. 269-276
Authors:
Tagashira, M
Nozato, N
Isonishi, S
Okamoto, A
Ochiai, K
Ohtake, Y
Citation: M. Tagashira et al., 5-hydroxy-4-oxo-L-norvaline depletes intracellular glutathione: a new modulator of drug resistance, BIOS BIOT B, 63(11), 1999, pp. 1953-1958